Developing, optimising, and manufacturing Advanced Therapy Medicinal Products (ATMP’s), such as Cell and Gene Therapy (CGT) products is extremely complex. The choice of a reliable Contract Development Manufacturing Organisation (CDMO) is one of the most critical steps determining your product’s future.

This report aims to provide a comprehensive study of the global market for Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services. Report Highlights:

(1) Global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services market size (value), history data from 2018-2022 and forecast data from 2023 to 2029.

(2) Global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services market competitive situation, revenue and market share, from 2018 to 2022.

(3) China Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services market competitive situation, revenue and market share, from 2018 to 2022.

(4) Global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.

(5) Global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services segment by type and by application and regional segment by type and by application.

(6) Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services industry supply chain, upstream, midstream and downstream analysis.

According to latest study, the global market for Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.

China Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.

The United States Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.

In terms of type, Gene Therapy segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, Oncology has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.

The global key manufacturers of Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services include AGC Biologics, BlueReg, Bio Elpida, Celonic, CGT Catapult, Catalent, Cellipont Bioservices, Lonza and Minaris Regenerative Medicine, etc. In 2022, the global top five players hold a share approximately % in terms of revenue.

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa

Market segment by type, covers

Gene Therapy

Cell Therapy

Tissue Engineered

Others

Market segment by application, can be divided into

Oncology

Cardiology

Central Nervous System

Others

Market segment by players, this report covers

AGC Biologics

BlueReg

Bio Elpida

Celonic

CGT Catapult

Catalent

Cellipont Bioservices

Lonza

Minaris Regenerative Medicine

Patheon

Rentschler Biopharma SE

Recipeharm

WuXi Advanced Therapies

1 Market Overview

1.1 Product Overview and Scope of Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services

1.2 Global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size and Forecast

1.3 China Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size and Forecast

1.4 China Market Percentage in Global

1.4.1 By Revenue, China Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Share in Global Market, 2018-2029

1.4.2 Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size: China VS Global, 2018-2029

1.5 Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Dynamics

1.5.1 Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Drivers

1.5.2 Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Restraints

1.5.3 Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Industry Trends

1.5.4 Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Industry Policy

2 Global Competitive Situation by Company

2.1 Global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue by Company (2018-2023)

2.2 Global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Participants, Market Position (Tier 1, Tier 2 and Tier 3)

2.3 Global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Concentration Ratio

2.4 Global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Mergers & Acquisitions, Expansion Plans

2.5 Global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Manufacturers Product Type

3 China Competitive Situation by Company

3.1 China Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue by Company (2018-2023)

3.2 China Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Participants, Market Position (Tier 1, Tier 2 and Tier 3)

3.3 China Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services, Revenue Percentage of Local Players VS Foreign Manufacturers (2018-2023)

4 Industry Chain Analysis

4.1 Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Industry Chain

4.2 Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Upstream Analysis

4.3 Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Midstream Analysis

4.4 Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Downstream Analysis

5 Sights by Type

5.1 Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Classification

5.1.1 Gene Therapy

5.1.2 Cell Therapy

5.1.3 Tissue Engineered

5.1.4 Others

5.2 By Type, Global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size & CAGR, 2018 VS 2022 VS 2029

5.3 By Type, Global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue, 2018-2029

6 Sights by Application

6.1 Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Segment by Application

6.1.1 Oncology

6.1.2 Cardiology

6.1.3 Central Nervous System

6.1.4 Others

6.2 By Application, Global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size & CAGR, 2018 VS 2022 VS 2029

6.3 By Application, Global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue, 2018-2029

7 Sales Sights by Region

7.1 By Region, Global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size, 2018 VS 2022 VS 2029

7.2 By Region, Global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size, 2018-2029

7.3 North America

7.3.1 North America Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size & Forecasts, 2018-2029

7.3.2 By Country, North America Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size Market Share

7.4 Europe

7.4.1 Europe Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size & Forecasts, 2018-2029

7.4.2 By Country, Europe Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size Market Share

7.5 Asia Pacific

7.5.1 Asia Pacific Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size & Forecasts, 2018-2029

7.5.2 By Country/Region, Asia Pacific Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size Market Share

7.6 South America

7.6.1 South America Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size & Forecasts, 2018-2029

7.6.2 By Country, South America Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size Market Share

7.7 Middle East & Africa

8 Sights by Country Level

8.1 By Country, Global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size & CAGR，2018 VS 2022 VS 2029

8.2 By Country, Global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size, 2018-2029

8.3 U.S.

8.3.1 U.S. Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size, 2018-2029

8.3.2 By Company, U.S. Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue Market Share, 2018-2023

8.3.3 By Type, U.S. Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue Market Share, 2022 VS 2029

8.3.4 By Application, U.S. Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue Market Share, 2022 VS 2029

8.4 Europe

8.4.1 Europe Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size, 2018-2029

8.4.2 By Company, Europe Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue Market Share, 2018-2023

8.4.3 By Type, Europe Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue Market Share, 2022 VS 2029

8.4.4 By Application, Europe Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue Market Share, 2022 VS 2029

8.5 China

8.5.1 China Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size, 2018-2029

8.5.2 By Company, China Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue Market Share, 2018-2023

8.5.3 By Type, China Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue Market Share, 2022 VS 2029

8.5.4 By Application, China Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue Market Share, 2022 VS 2029

8.6 Japan

8.6.1 Japan Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size, 2018-2029

8.6.2 By Company, Japan Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue Market Share, 2018-2023

8.6.3 By Type, Japan Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue Market Share, 2022 VS 2029

8.6.4 By Application, Japan Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue Market Share, 2022 VS 2029

8.7 South Korea

8.7.1 South Korea Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size, 2018-2029

8.7.2 By Company, South Korea Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue Market Share, 2018-2023

8.7.3 By Type, South Korea Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue Market Share, 2022 VS 2029

8.7.4 By Application, South Korea Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue Market Share, 2022 VS 2029

8.8 Southeast Asia

8.8.1 Southeast Asia Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size, 2018-2029

8.8.2 By Company, Southeast Asia Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue Market Share, 2018-2023

8.8.3 By Type, Southeast Asia Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue Market Share, 2022 VS 2029

8.8.4 By Application, Southeast Asia Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue Market Share, 2022 VS 2029

8.9 India

8.9.1 India Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size, 2018-2029

8.9.2 By Company, India Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue Market Share, 2018-2023

8.9.3 By Type, India Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue Market Share, 2022 VS 2029

8.9.4 By Application, India Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue Market Share, 2022 VS 2029

8.10 Middle East & Asia

8.10.1 Middle East & Asia Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size, 2018-2029

8.10.2 By Company, Middle East & Asia Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue Market Share, 2018-2023

8.10.3 By Type, Middle East & Asia Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue Market Share, 2022 VS 2029

8.10.4 By Application, Middle East & Asia Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue Market Share, 2022 VS 2029

9 Global Manufacturers Profile

9.1 AGC Biologics

9.1.1 AGC Biologics Company Information, Head Office, Market Area and Industry Position

9.1.2 AGC Biologics Company Profile and Main Business

9.1.3 AGC Biologics Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Models, Specifications and Application

9.1.4 AGC Biologics Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue and Gross Margin, 2018-2023

9.1.5 AGC Biologics Recent Developments

9.2 BlueReg

9.2.1 BlueReg Company Information, Head Office, Market Area and Industry Position

9.2.2 BlueReg Company Profile and Main Business

9.2.3 BlueReg Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Models, Specifications and Application

9.2.4 BlueReg Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue and Gross Margin, 2018-2023

9.2.5 BlueReg Recent Developments

9.3 Bio Elpida

9.3.1 Bio Elpida Company Information, Head Office, Market Area and Industry Position

9.3.2 Bio Elpida Company Profile and Main Business

9.3.3 Bio Elpida Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Models, Specifications and Application

9.3.4 Bio Elpida Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue and Gross Margin, 2018-2023

9.3.5 Bio Elpida Recent Developments

9.4 Celonic

9.4.1 Celonic Company Information, Head Office, Market Area and Industry Position

9.4.2 Celonic Company Profile and Main Business

9.4.3 Celonic Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Models, Specifications and Application

9.4.4 Celonic Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue and Gross Margin, 2018-2023

9.4.5 Celonic Recent Developments

9.5 CGT Catapult

9.5.1 CGT Catapult Company Information, Head Office, Market Area and Industry Position

9.5.2 CGT Catapult Company Profile and Main Business

9.5.3 CGT Catapult Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Models, Specifications and Application

9.5.4 CGT Catapult Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue and Gross Margin, 2018-2023

9.5.5 CGT Catapult Recent Developments

9.6 Catalent

9.6.1 Catalent Company Information, Head Office, Market Area and Industry Position

9.6.2 Catalent Company Profile and Main Business

9.6.3 Catalent Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Models, Specifications and Application

9.6.4 Catalent Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue and Gross Margin, 2018-2023

9.6.5 Catalent Recent Developments

9.7 Cellipont Bioservices

9.7.1 Cellipont Bioservices Company Information, Head Office, Market Area and Industry Position

9.7.2 Cellipont Bioservices Company Profile and Main Business

9.7.3 Cellipont Bioservices Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Models, Specifications and Application

9.7.4 Cellipont Bioservices Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue and Gross Margin, 2018-2023

9.7.5 Cellipont Bioservices Recent Developments

9.8 Lonza

9.8.1 Lonza Company Information, Head Office, Market Area and Industry Position

9.8.2 Lonza Company Profile and Main Business

9.8.3 Lonza Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Models, Specifications and Application

9.8.4 Lonza Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue and Gross Margin, 2018-2023

9.8.5 Lonza Recent Developments

9.9 Minaris Regenerative Medicine

9.9.1 Minaris Regenerative Medicine Company Information, Head Office, Market Area and Industry Position

9.9.2 Minaris Regenerative Medicine Company Profile and Main Business

9.9.3 Minaris Regenerative Medicine Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Models, Specifications and Application

9.9.4 Minaris Regenerative Medicine Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue and Gross Margin, 2018-2023

9.9.5 Minaris Regenerative Medicine Recent Developments

9.10 Patheon

9.10.1 Patheon Company Information, Head Office, Market Area and Industry Position

9.10.2 Patheon Company Profile and Main Business

9.10.3 Patheon Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Models, Specifications and Application

9.10.4 Patheon Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue and Gross Margin, 2018-2023

9.10.5 Patheon Recent Developments

9.11 Rentschler Biopharma SE

9.11.1 Rentschler Biopharma SE Company Information, Head Office, Market Area and Industry Position

9.11.2 Rentschler Biopharma SE Company Profile and Main Business

9.11.3 Rentschler Biopharma SE Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Models, Specifications and Application

9.11.4 Rentschler Biopharma SE Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue and Gross Margin, 2018-2023

9.11.5 Rentschler Biopharma SE Recent Developments

9.12 Recipeharm

9.12.1 Recipeharm Company Information, Head Office, Market Area and Industry Position

9.12.2 Recipeharm Company Profile and Main Business

9.12.3 Recipeharm Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Models, Specifications and Application

9.12.4 Recipeharm Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue and Gross Margin, 2018-2023

9.12.5 Recipeharm Recent Developments

9.13 WuXi Advanced Therapies

9.13.1 WuXi Advanced Therapies Company Information, Head Office, Market Area and Industry Position

9.13.2 WuXi Advanced Therapies Company Profile and Main Business

9.13.3 WuXi Advanced Therapies Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Models, Specifications and Application

9.13.4 WuXi Advanced Therapies Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue and Gross Margin, 2018-2023

9.13.5 WuXi Advanced Therapies Recent Developments

10 Conclusion

11 Appendix

11.1 Research Methodology

11.2 Data Source

11.2.1 Secondary Sources

11.2.2 Primary Sources

11.3 Market Estimation Model

11.4 Disclaimer

Table 1. Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size & CAGR: China VS Global, (US$ Million), 2018-2029_x000D_

Table 2. Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Restraints_x000D_

Table 3. Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Trends_x000D_

Table 4. Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Industry Policy_x000D_

Table 5. Global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue by Company (2018-2023) & (US$ million)_x000D_

Table 6. Global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue Market Share by Company (2018-2023)_x000D_

Table 7. Global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Manufacturers Market Concentration Ratio (CR3 and HHI)_x000D_

Table 8. Global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Mergers & Acquisitions, Expansion Plans_x000D_

Table 9. Global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Manufacturers Product Type_x000D_

Table 10. China Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue by Company (2018-2023) & (US$ million)_x000D_

Table 11. China Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue Market Share by Company (2018-2023)_x000D_

Table 12. Global Key Players of Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Upstream (Raw Materials)_x000D_

Table 13. Global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Typical Customers_x000D_

Table 14. Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Typical Distributors_x000D_

Table 15. By Type, Global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million_x000D_

Table 16. By Application, Global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million_x000D_

Table 17. By Region, Global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size, 2018 VS 2022 VS 2029, US$ Million_x000D_

Table 18. By Region, Global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue, 2018-2029, US$ Million_x000D_

Table 19. By Country, Global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue & CAGR，2018 VS 2022 VS 2029, US$ Million_x000D_

Table 20. By Country, Global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue, 2018-2029, US$ Million_x000D_

Table 21. By Country, Global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue Market Share, 2018-2029_x000D_

Table 22. AGC Biologics Company Information, Head Office, Market Area and Industry Position_x000D_

Table 23. AGC Biologics Company Profile and Main Business_x000D_

Table 24. AGC Biologics Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Models, Specifications and Application_x000D_

Table 25. AGC Biologics Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue and Gross Margin, 2018-2023_x000D_

Table 26. AGC Biologics Recent Developments_x000D_

Table 27. BlueReg Company Information, Head Office, Market Area and Industry Position_x000D_

Table 28. BlueReg Company Profile and Main Business_x000D_

Table 29. BlueReg Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Models, Specifications and Application_x000D_

Table 30. BlueReg Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue and Gross Margin, 2018-2023_x000D_

Table 31. BlueReg Recent Developments_x000D_

Table 32. Bio Elpida Company Information, Head Office, Market Area and Industry Position_x000D_

Table 33. Bio Elpida Company Profile and Main Business_x000D_

Table 34. Bio Elpida Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Models, Specifications and Application_x000D_

Table 35. Bio Elpida Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue and Gross Margin, 2018-2023_x000D_

Table 36. Bio Elpida Recent Developments_x000D_

Table 37. Celonic Company Information, Head Office, Market Area and Industry Position_x000D_

Table 38. Celonic Company Profile and Main Business_x000D_

Table 39. Celonic Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Models, Specifications and Application_x000D_

Table 40. Celonic Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue and Gross Margin, 2018-2023_x000D_

Table 41. Celonic Recent Developments_x000D_

Table 42. CGT Catapult Company Information, Head Office, Market Area and Industry Position_x000D_

Table 43. CGT Catapult Company Profile and Main Business_x000D_

Table 44. CGT Catapult Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Models, Specifications and Application_x000D_

Table 45. CGT Catapult Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue and Gross Margin, 2018-2023_x000D_

Table 46. CGT Catapult Recent Developments_x000D_

Table 47. Catalent Company Information, Head Office, Market Area and Industry Position_x000D_

Table 48. Catalent Company Profile and Main Business_x000D_

Table 49. Catalent Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Models, Specifications and Application_x000D_

Table 50. Catalent Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue and Gross Margin, 2018-2023_x000D_

Table 51. Catalent Recent Developments_x000D_

Table 52. Cellipont Bioservices Company Information, Head Office, Market Area and Industry Position_x000D_

Table 53. Cellipont Bioservices Company Profile and Main Business_x000D_

Table 54. Cellipont Bioservices Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Models, Specifications and Application_x000D_

Table 55. Cellipont Bioservices Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue and Gross Margin, 2018-2023_x000D_

Table 56. Cellipont Bioservices Recent Developments_x000D_

Table 57. Lonza Company Information, Head Office, Market Area and Industry Position_x000D_

Table 58. Lonza Company Profile and Main Business_x000D_

Table 59. Lonza Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Models, Specifications and Application_x000D_

Table 60. Lonza Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue and Gross Margin, 2018-2023_x000D_

Table 61. Lonza Recent Developments_x000D_

Table 62. Minaris Regenerative Medicine Company Information, Head Office, Market Area and Industry Position_x000D_

Table 63. Minaris Regenerative Medicine Company Profile and Main Business_x000D_

Table 64. Minaris Regenerative Medicine Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Models, Specifications and Application_x000D_

Table 65. Minaris Regenerative Medicine Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue and Gross Margin, 2018-2023_x000D_

Table 66. Minaris Regenerative Medicine Recent Developments_x000D_

Table 67. Patheon Company Information, Head Office, Market Area and Industry Position_x000D_

Table 68. Patheon Company Profile and Main Business_x000D_

Table 69. Patheon Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Models, Specifications and Application_x000D_

Table 70. Patheon Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue and Gross Margin, 2018-2023_x000D_

Table 71. Patheon Recent Developments_x000D_

Table 72. Rentschler Biopharma SE Company Information, Head Office, Market Area and Industry Position_x000D_

Table 73. Rentschler Biopharma SE Company Profile and Main Business_x000D_

Table 74. Rentschler Biopharma SE Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Models, Specifications and Application_x000D_

Table 75. Rentschler Biopharma SE Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue and Gross Margin, 2018-2023_x000D_

Table 76. Rentschler Biopharma SE Recent Developments_x000D_

Table 77. Recipeharm Company Information, Head Office, Market Area and Industry Position_x000D_

Table 78. Recipeharm Company Profile and Main Business_x000D_

Table 79. Recipeharm Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Models, Specifications and Application_x000D_

Table 80. Recipeharm Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue and Gross Margin, 2018-2023_x000D_

Table 81. Recipeharm Recent Developments_x000D_

Table 82. WuXi Advanced Therapies Company Information, Head Office, Market Area and Industry Position_x000D_

Table 83. WuXi Advanced Therapies Company Profile and Main Business_x000D_

Table 84. WuXi Advanced Therapies Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Models, Specifications and Application_x000D_

Table 85. WuXi Advanced Therapies Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue and Gross Margin, 2018-2023_x000D_

Table 86. WuXi Advanced Therapies Recent Developments_x000D_

List of Figure_x000D_

Figure 1. Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Picture_x000D_

Figure 2. Global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Industry Market Size and Forecast (US$ million) & (2018-2029)_x000D_

Figure 3. China Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue and Forecast (US$ million) & (2018-2029)_x000D_

Figure 4. 2018-2029 China Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Share of Global_x000D_

Figure 5. Global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Key Participants, Market Share, 2021 VS 2022 VS 2023_x000D_

Figure 6. Global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2018-2023_x000D_

Figure 7. China Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Key Participants, Market Share, 2021 VS 2022 VS 2023_x000D_

Figure 8. China Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023_x000D_

Figure 9. Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Industry Chain_x000D_

Figure 10. Gene Therapy_x000D_

Figure 11. Cell Therapy_x000D_

Figure 12. Tissue Engineered_x000D_

Figure 13. Others_x000D_

Figure 14. By Type, Global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue, 2018-2029, US$ Million_x000D_

Figure 15. By Type, Global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue Market Share, 2018-2029_x000D_

Figure 16. Oncology_x000D_

Figure 17. Cardiology_x000D_

Figure 18. Central Nervous System_x000D_

Figure 19. Others_x000D_

Figure 20. By Application, Global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue, 2018-2029, US$ Million_x000D_

Figure 21. By Application, Global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue Market Share, 2018-2029_x000D_

Figure 22. By Region, Global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue Market Share, 2018-2029_x000D_

Figure 23. North America Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue & Forecasts, 2018-2029, US$ Million_x000D_

Figure 24. By Country, North America Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue Market Share, 2018-2023_x000D_

Figure 25. Europe Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue & Forecasts, 2018-2029, US$ Million_x000D_

Figure 26. By Country, Europe Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue Market Share, 2018-2023_x000D_

Figure 27. Asia Pacific Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue & Forecasts, 2018-2029, US$ Million_x000D_

Figure 28. By Country/Region, Asia Pacific Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue Market Share, 2018-2023_x000D_

Figure 29. South America Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue & Forecasts, 2018-2029, US$ Million_x000D_

Figure 30. By Country, South America Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue Market Share, 2018-2023_x000D_

Figure 31. Middle East & Africa Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue & Forecasts, 2018-2029, US$ Million_x000D_

Figure 32. U.S. Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue, 2018-2029, (US$ Million)_x000D_

Figure 33. By Company, U.S. Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Share, 2018-2023_x000D_

Figure 34. By Type, U.S. Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue Market Share, 2022 VS 2029_x000D_

Figure 35. By Application, U.S. Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue Market Share, 2022 VS 2029_x000D_

Figure 36. Europe Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue, 2018-2029, (US$ Million)_x000D_

Figure 37. By Company, Europe Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Share, 2018-2023_x000D_

Figure 38. By Type, Europe Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue Market Share, 2022 VS 2029_x000D_

Figure 39. By Application, Europe Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue Market Share, 2022 VS 2029_x000D_

Figure 40. China Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue, 2018-2029, (US$ Million)_x000D_

Figure 41. By Company, China Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Share, 2018-2023_x000D_

Figure 42. By Type, China Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue Market Share, 2022 VS 2029_x000D_

Figure 43. By Application, China Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue Market Share, 2022 VS 2029_x000D_

Figure 44. Japan Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue, 2018-2029, (US$ Million)_x000D_

Figure 45. By Company, Japan Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Share, 2018-2023_x000D_

Figure 46. By Type, Japan Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue Market Share, 2022 VS 2029_x000D_

Figure 47. By Application, Japan Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue Market Share, 2022 VS 2029_x000D_

Figure 48. South Korea Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue, 2018-2029, (US$ Million)_x000D_

Figure 49. By Company, South Korea Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Share, 2018-2023_x000D_

Figure 50. By Type, South Korea Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue Market Share, 2022 VS 2029_x000D_

Figure 51. By Application, South Korea Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue Market Share, 2022 VS 2029_x000D_

Figure 52. Southeast Asia Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue, 2018-2029, (US$ Million)_x000D_

Figure 53. By Company, Southeast Asia Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Share, 2018-2023_x000D_

Figure 54. By Type, Southeast Asia Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue Market Share, 2022 VS 2029_x000D_

Figure 55. By Application, Southeast Asia Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue Market Share, 2022 VS 2029_x000D_

Figure 56. India Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue, 2018-2029, (US$ Million)_x000D_

Figure 57. By Company, India Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Share, 2018-2023_x000D_

Figure 58. By Type, India Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue Market Share, 2022 VS 2029_x000D_

Figure 59. By Application, India Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue Market Share, 2022 VS 2029_x000D_

Figure 60. Middle East & Asia Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue, 2018-2029, (US$ Million)_x000D_

Figure 61. By Company, Middle East & Asia Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Share, 2018-2023_x000D_

Figure 62. By Type, Middle East & Asia Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue Market Share, 2022 VS 2029_x000D_

Figure 63. By Application, Middle East & Asia Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue Market Share, 2022 VS 2029_x000D_

Figure 64. Research Methodology_x000D_

Figure 65. Breakdown of Primary Interviews_x000D_

Figure 66. Bottom-up Approaches_x000D_

Figure 67. Top-down Approaches_x000D_

_x000D_

Methodology/Research Approach

This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.

Research Programs/Design

Historical Data (2015-2019)	Industry Trends Competitive Landscape By Company Expansion Mergers and Acquisitions Market Segment by Type by Application By Regions/ Geography	Value Status and Outlook Value for Major Players Market Share Growth Rate Present Situation Analysis Value Market Share Growth Rate Present Situation Analysis
Influencing Factors	Market Environment Government Policy Technological Changes Market Risks	Market Drivers Growing Demand of Downstream Reduction in Cost
Market Forecast (2021-2026)	Overall Size by Type by Application By Regions/Geography	Key Data (Value) Market Share Growth Rate CAGR (2021-2026)

Market Size Estimation

Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).

The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.

Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.

All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report

The following figure shows an illustrative representation of the overall market size estimation process used for this study.

Market Breakdown and Data Triangulation

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.

Data Source

Secondary Sources

Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.

Market Size	Segmental value Geographic Penetration Product Adoption Rate for Different market	Journals, Websites, and Press Releases Annual Reports and SEC Filings Company Websites and Press Releases Public and Paid Databases Market Intellix Data Repository
Market Position of Top Company	Product Financials Geographic value Mix Total Company value Business/Segmental value Mix
Qualitative Analysis	Influence Factors Market Potential Market Risks and Opportunities Industry Trends Geographical Features Government Policies	Company Websites and Press Releases Public and Paid Databases Annual Reports Industry Associations Market Intellix Data Repository

Primary Sources

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.

Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.

Key Executives Interviewed

Key Data Information from Primary Sources

Primary Sources	Parameters	Key Data
Market Segments(by Application, by Type)	Value by Type Status and Forecast Value by Application Value by Regions, Status and Forecast (2021-2026)	Value Market Share by Type Value Growth Rate by Type Value by Application Percentage and Growth Rate by Application Value Growth Rate and Market Share by Regions Market Size Status and Forecast (2021-2026)
Total Market	Overall Size, Status and Forecast	Market Size Status and Forecast (2021-2026)